Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.
Aktiia focuses on continuous and accurate blood pressure monitoring to address the global challenge of hypertension, which affects over 1.4 billion people and contributes to more than 18 million deaths annually. Founded on two decades of research, Aktiia's innovative technology combines optical sensors with clinically validated software algorithms to provide personalized, medical-grade blood pressure and heart rate data. This continuous monitoring enables individuals, researchers, and clinicians to gain deeper insights into hypertension, fostering more effective and personalized patient care. By improving accessibility and accuracy in blood pressure management, Aktiia aims to change the approach to this critical health issue, ultimately enhancing the understanding and treatment of high blood pressure.
Rogo
Series B in 2025
Rogo is the secure, state-of-the-art Generative AI platform purpose-built for elite financial institutions. Trusted by thousands of investment bankers, asset managers, and private equity professionals, Rogo streamlines workflows, rapidly unlocks strategic insights, and saves valuable time—all within the industry's most rigorous security standards. Empower your team to analyze, automate, and innovate with confidence
Tempero Bio
Series B in 2025
Tempero Bio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment and prevention of substance use disorders. The company aims to address the challenges faced by individuals struggling with addiction, providing transformative solutions that help patients overcome treatment obstacles and support their recovery journey. Through its specialized approach, Tempero Bio is dedicated to improving the lives of those affected by substance use disorders and related conditions.
Regie.ai
Series B in 2025
Regie.ai is a developer of an AI-powered platform that focuses on enhancing sales engagement and automating outbound prospecting. Its product, RegieOne, combines various functionalities such as sales engagement, parallel dialing, data enrichment, and intent analysis, allowing operations teams to manage their processes efficiently from a centralized interface. Additionally, Regie.ai's platform facilitates the creation, testing, and analysis of personalized sales campaigns, thereby improving engagement and optimizing the performance of frontline sales teams. Through its innovative approach, Regie.ai aims to streamline sales workflows and drive better outcomes for businesses.
Nomagic
Series B in 2025
Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.
Rad AI
Series C in 2025
Rad AI, Inc. is a company based in Berkeley, California, that specializes in developing an artificial intelligence platform designed to automate report generation for radiologists. Founded in 2018, Rad AI's solution streamlines the radiology workflow by automating repetitive tasks, thereby enhancing efficiency and accuracy while addressing issues of clinician burnout. The platform utilizes AI to generate report impressions, allowing radiologists to dictate findings using voice recognition technology, identify errors, and customize recommendations. By integrating smoothly with existing workflows, Rad AI aims to improve patient care and support radiologists in delivering accurate and timely reports.
Jones
Series B in 2025
The Jones Agency, Inc. is a liability insurance underwriting company that specializes in serving general construction and property management contractors. Founded in 2016 and based in New York, it provides insurance solutions tailored for various professions, including contractors, electricians, HVAC technicians, and landscapers. In addition to its underwriting services, Jones offers a software platform designed to streamline liability management for real estate companies, addressing the complexities of insurance compliance. This innovative approach aims to simplify the traditionally cumbersome process of managing insurance certificates for owners, managers, and developers within the commercial real estate sector. Through its services, Jones seeks to enhance efficiency and effectiveness in insurance management for its clients.
Speak
Series C in 2024
Speak is an AI-powered language-learning mobile application focused on helping users improve their English skills. The app employs advanced speech recognition technology, allowing users to engage in conversations about real-world scenarios. This approach enables individuals to better understand English words, even when spoken with strong accents, and facilitates a more intuitive learning experience. By providing personalized and interactive lessons, Speak aims to make the process of learning English accessible and efficient for users of varying proficiency levels.
Vitara Biomedical
Series B in 2024
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.
LuxWall
Series B in 2024
LuxWall is a building materials company that pioneers the design and manufacture of vacuum-insulated glass. LuxWall produces glass that acts as transparent insulation, providing thermal insulation values comparable to fiberglass wall insulation. With widespread adoption, LuxWall's patented technology has the potential to reduce global carbon emissions by more than 0.5 gigatonnes per year. The company was founded in 2020 and is headquartered in Ypsilanti, Michigan, United States.
Imprint
Series C in 2024
Imprint is a financial services company founded in 2020 and based in New York, specializing in payments, rewards, and loyalty services. The firm has developed a full-stack payments and loyalty platform that facilitates payment processing for merchants and consumers. This platform allows users to execute financial transactions while also earning loyalty and reward points, streamlining the management of daily financial transactions. Imprint aims to enhance the payment experience by integrating rewards and loyalty features, making it easier for users to engage with their financial activities.
Vanan Online Services
Series B in 2024
Vanan Online Services is a global provider of language support services, catering to both individual and business clients. The company specializes in a wide range of services, including audio and video transcription, certified translation, closed captioning, subtitling, document typing, and legal typing. Additionally, Vanan offers audio voiceover, video animation, and video editing services.
Fortera
Series C in 2024
Fortera is focused on developing innovative cement products that significantly reduce carbon dioxide emissions associated with concrete production. The company has created a process that captures industrial carbon emissions and mineralizes them to produce a less carbon-intensive form of concrete. This method not only aims to lower the environmental impact of construction but also enhances the performance characteristics of their products compared to traditional concrete. By providing a more sustainable alternative, Fortera contributes to the global effort to mitigate greenhouse gas emissions, addressing a critical challenge in the construction industry.
Speak
Series B in 2024
Speak is an AI-powered language-learning mobile application focused on helping users improve their English skills. The app employs advanced speech recognition technology, allowing users to engage in conversations about real-world scenarios. This approach enables individuals to better understand English words, even when spoken with strong accents, and facilitates a more intuitive learning experience. By providing personalized and interactive lessons, Speak aims to make the process of learning English accessible and efficient for users of varying proficiency levels.
Waabi
Series B in 2024
Waabi is an artificial intelligence company based in Toronto, Canada, focused on developing autonomous driving technology for the transportation sector. Founded in 2021 by Raquel Urtasun, Waabi offers a self-driving solution called the Waabi Driver, specifically designed for integration with trucks. The company's technology aims to facilitate large-scale commercialization and safe deployment of autonomous vehicles in the logistics and transportation industries. By utilizing advanced deep learning, probabilistic inference, and complex optimization techniques, Waabi's software is capable of complex reasoning and is end-to-end trainable. This approach allows clients to test driving scenarios and safety-critical edge cases in a closed-loop simulator, significantly reducing the need for extensive real-world testing and enhancing safety and cost-effectiveness in the deployment of autonomous trucking solutions.
Found
Series C in 2024
Found is a financial platform tailored for self-employed individuals, offering a suite of services that simplifies business banking, bookkeeping, and tax management. The platform features built-in expense tracking and a dedicated tax savings account, allowing users to manage their finances efficiently. With no account fees and real-time business reporting, Found aims to streamline operations for self-employed professionals, enabling them to focus on growing their businesses. By addressing the unique challenges faced by self-employed individuals, Found is dedicated to helping them achieve their entrepreneurial goals.
Cyberhaven
Series C in 2024
Cyberhaven, Inc., established in 2014 and headquartered in Boston, Massachusetts, specializes in enterprise cybersecurity. The company's core offering is a Data Detection and Response platform designed to safeguard intellectual property from theft and insider threats. This platform assesses internal actions across an organization, identifying risky behaviors before they result in a breach. It provides full-context data tracing to minimize false positives and negatives, and accelerates incident response investigations, enabling clients to protect their data efficiently. Cyberhaven's technology covers the protection of sensitive documents across various platforms, including Office 365, on-premise SharePoint, and Google Apps. The company operates globally with additional offices in Palo Alto, California; Lausanne, Switzerland; and Kiev, Ukraine.
PolyAI
Series C in 2024
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Founded in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on creating enterprise voice assistants capable of engaging in natural conversations with customers. These assistants utilize advanced machine learning and natural language processing to understand and respond to customer inquiries, regardless of phrasing or dialect. The platform supports features such as multilingual capabilities, data acquisition, and dynamic flow design, facilitating the creation of human-like interactions and improving customer service experiences across various industries.
Glydways
Series B in 2024
Glydways, formerly known as Wayfarer, is a transportation technology and clean energy company located in South San Francisco, California. The company focuses on designing, manufacturing, installing, and operating affordable autonomous transportation systems that cater to various capacity needs, including low, medium, and extremely high-capacity demands. Glydways aims to transform mobility and public transportation by providing a system that operates profitably at existing mass transit fares. Its solutions are designed for efficiency, featuring a small physical and environmental footprint, with zero greenhouse gas emissions. By offering a personal, private car experience, Glydways enhances passenger capacity while minimizing costs and environmental impact.
Li Industries
Series B in 2024
Li Industries is a start-up dedicated to advancing lithium-ion battery recycling technologies. The company focuses on reclaiming materials from end-of-life batteries used in electric vehicles, consumer electronics, and various energy storage systems. By utilizing direct recycling technology, Li Industries specializes in recovering valuable metals such as lithium, cobalt, and nickel, which are essential for battery production. Their innovative electrochemical flow system allows for non-destructive lithiation and optimizes the post-treatment of recovered materials, enhancing the efficiency of the recycling process. Through its efforts, Li Industries aims to minimize environmental waste, lower emissions, and reduce the costs associated with lithium-ion battery manufacturing, thereby promoting a more sustainable supply chain for battery materials.
Rad AI
Series B in 2024
Rad AI, Inc. is a company based in Berkeley, California, that specializes in developing an artificial intelligence platform designed to automate report generation for radiologists. Founded in 2018, Rad AI's solution streamlines the radiology workflow by automating repetitive tasks, thereby enhancing efficiency and accuracy while addressing issues of clinician burnout. The platform utilizes AI to generate report impressions, allowing radiologists to dictate findings using voice recognition technology, identify errors, and customize recommendations. By integrating smoothly with existing workflows, Rad AI aims to improve patient care and support radiologists in delivering accurate and timely reports.
Karius
Series C in 2024
Karius, Inc. is a life sciences company based in Redwood City, California, specializing in genomic insights for infectious diseases. The company offers a non-invasive blood test known as the Karius Test, which utilizes sequencing of microbial cell-free DNA to identify and quantify various pathogens, including bacteria, DNA viruses, fungi, and parasites. This test is particularly useful for diagnosing complicated pneumonia, infections in immunocompromised patients, and endocarditis. By mapping the microbial landscape of each patient from a single blood draw, Karius aims to assist clinicians in making rapid and informed treatment decisions. The company's laboratory is CLIA-certified and CAP-accredited, ensuring high standards in clinical laboratory testing. Additionally, Karius provides laboratory services for pathogen biomarker detection tailored to biopharmaceutical companies.
Anrok
Series B in 2024
Anrok is a sales tax software solution tailored for SaaS businesses, providing a comprehensive platform for monitoring, calculating, and remitting sales tax across various financial systems. The software streamlines the sales tax process by automating the manual tasks typically associated with tax management, helping clients minimize errors and reduce expenses related to sales tax and value-added tax. Anrok's features include customizable configurations, filing frequency alerts, and enhanced visibility, all designed to facilitate accurate tax handling. This unified approach allows finance teams in organizations of all sizes to manage their tax obligations efficiently, generate audit-ready reports, and maintain compliance effectively.
Collaborative Robotics
Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.
Varda
Series B in 2024
Varda Space Industries, Inc. is a space manufacturing startup based in San Francisco, California, founded in 2020 by Delian Asparouhov and Trae Stephens. The company specializes in creating products in space that are intended for terrestrial applications, leveraging the unique advantages of low gravity. Varda aims to establish an infrastructure for harvesting materials from asteroids, enabling the production of new products in space. This approach not only facilitates the manufacturing of innovative goods but also promotes sustainability by reducing reliance on the destructive extraction of Earth's resources.
Skyflow
Series B in 2024
Skyflow, Inc. is a technology company based in Los Altos, California, that specializes in providing a privacy API for managing sensitive user information, such as social security numbers. Founded in 2017 and formerly known as Prekari Labs, the company has developed a secure data privacy platform that integrates a customer data vault to help businesses handle personally identifiable information (PII) in compliance with various regulations, including PCI, HIPAA, GDPR, and CCPA. Skyflow's platform utilizes advanced encryption and tokenization techniques to protect sensitive data across different applications, ensuring that businesses can securely manage, store, and access this information while maintaining the privacy and security of their customers.
Loyal
Series B in 2024
Loyal is a biotechnology company focused on developing veterinary pharmaceuticals aimed at extending the lifespan and improving the health span of dogs. By creating medications that target the aging process, Loyal seeks to delay or prevent the onset of age-related diseases, including cancer, heart disease, and metabolic disorders. The company's innovative approach involves quantifying and regulating the biological processes associated with aging, which helps to mitigate the severity of these ailments. Through its research and product development, Loyal strives to ensure that dogs can enjoy longer, healthier lives, ultimately benefiting both pets and their owners.
CureSkin
Series B in 2024
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The app utilizes computer vision technology to analyze user-uploaded photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on the analysis, CureSkin recommends personalized treatment plans, skincare products, and connects users with dermatologists for follow-up consultations. By offering these services, CureSkin aims to provide accessible and effective skin health solutions, particularly for individuals who may not have easy access to trained professionals.
Siolta Therapeutics
Series C in 2024
Siolta Therapeutics, Inc. is a clinical-stage biotech company based in San Francisco, California, focused on developing microbiome-based therapeutics and diagnostics aimed at preventing and treating chronic inflammatory diseases, particularly asthma and atopic conditions. Founded in 2016, the company utilizes its expertise in the developing gut microbiome to promote immune tolerance. Siolta's platform includes the development of pharmaceutical-grade anaerobic organisms and microbiome-based diagnostics that support precision medicine. By leveraging insights from human microbiome studies, Siolta Therapeutics aims to create targeted microbial therapeutics that address the underlying causes of inflammatory diseases, enabling a new approach to prevention and treatment.
Inkitt
Series C in 2024
Inkitt GmbH operates an online community that connects writers and readers, facilitating the sharing and promotion of stories across various genres, including horror, romance, and sci-fi. Founded in 2013 and based in Berlin, the company publishes books using crowd wisdom and data-driven insights to predict future bestsellers. Its core platform, Inkitt, allows authors to share their works in progress and receive feedback from readers, who can access these manuscripts for free for a limited time. In addition to Inkitt, the company also operates Galatea, which sells optimized stories in a chapter-by-chapter format, and GalateaTV, which adapts successful e-books into short-form television series. Inkitt's proprietary ReadRank algorithm identifies high-potential stories, enhancing the overall user experience and driving its publishing success. The company aims to leverage AI for hyper-personalization, tailoring stories to individual reader preferences across multiple media formats.
Koloma
Series B in 2024
Koloma is a geologic hydrogen company focused on identifying and commercializing geologic hydrogen resources. By utilizing its technology and proprietary data, Koloma develops data-driven solutions for energy transition resource development. The company's initiatives aim to reduce global carbon emissions, providing businesses with the tools to lower their carbon footprint and contribute to climate change mitigation efforts. Through its innovative approach, Koloma seeks to advance clean energy technology and support the transition towards a more sustainable energy future.
Eligo Bioscience
Series B in 2023
Eligo Bioscience S.A.S is a biotechnology company based in Paris, France, that specializes in the development of Eligobiotics, a new class of antimicrobials designed to target specific bacteria based on their genetic makeup. Founded in 2014, the company utilizes a combination of CRISPR/Cas technology and engineered phage capsids to create antibiotics capable of addressing microbiome-related diseases and combating resistant pathogens. These programmed antimicrobials aim to eradicate virulent bacteria within the human microbiome, facilitating the creation of advanced therapeutics for conditions caused by superbugs. Eligo Bioscience's innovative approach positions it at the forefront of microbiome precision therapies and next-generation antibiotic solutions.
Tabnine
Series B in 2023
Tabnine, Inc. is an artificial intelligence company based in Toronto, Canada, that specializes in autocompletion software for developers. Founded in 2018, Tabnine offers an AI-powered coding assistant designed to help development teams enhance their coding efficiency while maintaining privacy and security. The platform predicts and autocompletes lines of code based on context and learned programming patterns, enabling developers to write software more seamlessly. Additionally, it includes features for analyzing code snippets and leveraging open-source code effectively. Tabnine's capabilities extend to providing an AI chat agent that can explain code and generate code, tests, and documentation from plain language prompts, thereby reducing errors and streamlining the software development process. Tabnine operates as a subsidiary of Codota Dot Com Ltd.
Traba
Series B in 2023
Traba operates a human resource marketplace designed to connect industrial businesses with reliable workers for open shifts. The platform facilitates the matching of workers with opportunities in warehouses, distribution centers, and event venues, allowing both parties to maximize productivity and earning potential. By streamlining the process of filling shifts, Traba enables businesses to maintain operational efficiency while providing workers with accessible employment opportunities.
Glydways
Series B in 2023
Glydways, formerly known as Wayfarer, is a transportation technology and clean energy company located in South San Francisco, California. The company focuses on designing, manufacturing, installing, and operating affordable autonomous transportation systems that cater to various capacity needs, including low, medium, and extremely high-capacity demands. Glydways aims to transform mobility and public transportation by providing a system that operates profitably at existing mass transit fares. Its solutions are designed for efficiency, featuring a small physical and environmental footprint, with zero greenhouse gas emissions. By offering a personal, private car experience, Glydways enhances passenger capacity while minimizing costs and environmental impact.
Farther
Series B in 2023
Farther is a technology-driven wealth management firm founded in 2019, aimed at serving high-net-worth professionals with a holistic approach to financial management. The firm integrates expert financial advisors with advanced technology to enhance client experiences and deliver personalized advice. Farther's platform utilizes a proprietary algorithm to provide tailored investment recommendations, focusing on allocations of exchange-traded funds based on individual client data, financial situations, and risk tolerance. By combining personal service with sophisticated analytics, Farther seeks to redefine wealth management standards, ensuring that clients receive both trusted guidance and innovative financial solutions to achieve their long-term financial goals.
Mighty Buildings
Series B in 2023
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of 3D printed custom homes. Utilizing advanced construction technology, the company employs 3D printing, robotics, and automation to create modular homes that aim to disrupt the residential housing market. Mighty Buildings has developed a proprietary building material known as Light Stone Material (LSM), which mimics synthetic stone and provides advantages such as faster construction, zero waste, and improved thermal regulation compared to traditional materials like concrete, wood, or steel. The company's innovative approach focuses on producing prefabricated, environmentally friendly, and climate-resilient homes, thereby facilitating smart urban development and making housing more affordable.
Viome Life Sciences
Series C in 2023
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Gail
Series B in 2023
GAIL is a technology company specializing in AI-driven conversational automation. It serves primarily insurance agencies and other regulated industries, offering virtual AI employees to automate sales, support, and customer engagement round the clock. The platform facilitates seamless integration and easy onboarding, aiming to reduce operational costs and enhance efficiency. Notably, GAIL's AI can communicate in multiple languages via speech, SMS, email, and WhatsApp, providing recordings, transcripts, analytics, and follow-ups as needed.
Neon
Series B in 2023
Neon is a cloud-native, fully managed Postgres as a service. By separating storage from computing, Neon offers autoscaling, branching, and bottomless storage to give developers a simple, reliable, and powerful experience. Neon aims to provide a highly performant and cost-effective database infrastructure by leveraging cloud-native technologies and innovative architectural features.
Speak
Series B in 2023
Speak is an AI-powered language-learning mobile application focused on helping users improve their English skills. The app employs advanced speech recognition technology, allowing users to engage in conversations about real-world scenarios. This approach enables individuals to better understand English words, even when spoken with strong accents, and facilitates a more intuitive learning experience. By providing personalized and interactive lessons, Speak aims to make the process of learning English accessible and efficient for users of varying proficiency levels.
SURGE Therapeutics
Series B in 2023
SURGE Therapeutics is dedicated to enhancing cancer patient survival through innovative approaches in immunotherapy. The company has developed a proprietary injectable biodegradable hydrogel designed for the prolonged and localized release of cancer immunotherapy following surgical tumor resection. By targeting the administration of treatment to specific areas at the optimal time, SURGE Therapeutics aims to improve the effectiveness of immunotherapy, allowing for both intravenous and intratumoral injections. This technology seeks to disrupt traditional cancer treatment paradigms and provide better outcomes for patients.
TeraWatt Technology
Series C in 2023
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, specializes in the design and development of lithium-ion rechargeable batteries for various electrified applications. The company focuses on producing batteries that combine energy and power density with safety, catering to the needs of industrial clients. Through advanced engineering practices and efficient production processes, TeraWatt Technology aims to provide long-lasting, safe, and reliable power alternatives, supporting a wide range of electrification initiatives. Additionally, TeraWatt has a subsidiary located in Tokyo, Japan, further expanding its reach in the global market.
Ceibo
Series B in 2023
Ceibo is an industrial biotechnology company dedicated to providing innovative solutions for the mining industry, particularly in the production of critical minerals essential for the clean energy transition. The company has developed proprietary technology for leaching copper sulfide, which enhances recovery from both primary and secondary sulfide ores rich in chalcopyrite. In addition to its leaching technology, Ceibo has implemented technologies aimed at dust suppression in mining operations. Currently, Ceibo operates within several large mining assets owned by prominent mining companies, focusing on optimizing processes, reducing costs, and promoting environmentally sustainable practices with a commitment to zero waste activity.
Nomba
Series B in 2023
Nomba is a fintech company focused on providing accessible and affordable financial software solutions for businesses in Africa. The company offers a range of services, including business savings accounts, joint savings options, card payments, and POS terminal management. Nomba's platform enables users to perform various financial transactions, such as paying bills, transferring money, purchasing airtime and TV subscriptions, and managing electricity payments. Customers can engage with Nomba's services through multiple digital channels, including mobile, web, and USSD, as well as through a network of agents. By streamlining these financial processes, Nomba aims to enhance the financial capabilities of businesses and individuals across the continent.
Replit
Series B in 2023
Replit is a San Francisco-based company founded in 2016 that operates a browser-based integrated development environment (IDE) designed to simplify coding for users of all skill levels. The platform supports over 50 programming languages, allowing developers to create applications and websites directly from their browsers on any operating system, including mobile devices. Replit emphasizes accessibility and collaboration, providing features such as real-time coding collaboration and communal workspaces. Users can easily build, deploy, save, and share their code projects, making the platform a versatile tool for both individual developers and teams working together.
Lexion
Series B in 2023
Lexion is a Seattle-based company that specializes in developing a software-as-a-service (SaaS) application leveraging artificial intelligence and natural language processing to enhance contract management. Its system organizes contracts in a centralized platform, automatically reading and interpreting legal terms, policies, and documents. By extracting key information such as termination notices, renewal dates, and payment terms, Lexion provides businesses with valuable insights and ensures critical contract obligations are tracked efficiently. The software integrates with various business, storage, and signature systems, streamlining workflows and enabling companies to save time and money through improved contract oversight.
Mojo Vision
Series C in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Fulfil Solutions
Series B in 2023
Fulfil Solutions specializes in developing custom robotic automation technology aimed at enhancing the online grocery supply chain. The company focuses on creating fully automated fulfillment systems that address various challenges through a combination of mechanical design, software, robotics, computer vision, and deep learning. By enabling efficient picking and packing across all product categories and temperature zones, Fulfil Solutions helps businesses achieve customer-centric and sustainable operations while minimizing labor requirements and space utilization. The company's mission is to reduce waste, environmental impact, and emissions, ultimately making online grocery services more profitable and scalable.
Light Field Lab
Series B in 2023
Light Field Lab, Inc. is a technology startup focused on developing holographic capture display systems. Founded in 2017 and based in San Jose, California, the company creates innovative solutions that generate three-dimensional holographic images that can be viewed from multiple angles without the need for head-mounted devices. Its technology aims to project 3D holograms into living spaces, allowing users to experience immersive visuals that respond dynamically to their viewpoint. Additionally, Light Field Lab offers integrated processing and imaging solutions designed to deliver these visuals over commercial network speeds. The company is also working on a universal application programming interface to facilitate the adaptation of existing content for its holographic displays. With a mission to enable a holographic future, Light Field Lab seeks to unlock new business opportunities across both consumer and enterprise markets.
IgGenix
Series B in 2023
IgGenix, Inc. is a biotechnology company focused on developing innovative antibody therapeutics for the treatment of food and other severe allergies. Founded in 2019 and based in South San Francisco, California, the company specializes in isolating and transforming allergen-specific IgE antibodies into IgG antibodies. This process aims to alleviate and prevent allergic reactions by suppressing the allergic cascade. IgGenix captures and analyzes rare human B cells that produce allergen-binding antibodies and engineers these cells to enhance their immune-modulating properties. By addressing critical needs in the medical industry, IgGenix seeks to provide effective solutions for life-threatening allergic reactions.
Synchron
Series C in 2022
Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.
Bionaut Labs
Series B in 2022
Bionaut Labs, Inc. is a biotechnology company based in Palo Alto, California, founded in 2016. The company specializes in developing a novel intra-tissue navigation platform utilizing Bionaut nano/micro robots that operate within the body. This innovative technology enables precise anatomical targeting for the treatment of central nervous system disorders, offering a new approach to precision medicine. By employing remote-controlled micro-robots, Bionaut Labs enhances the development of therapeutics, making advanced technologies like gene therapy and CRISPR-Cas9 feasible in challenging clinical scenarios. The Bionaut platform allows medical professionals to access any anatomic location within the body, facilitating the automation of complex procedures while eliminating the need for external incisions, thereby improving patient outcomes for those with limited treatment options.
Viome Life Sciences
Series C in 2022
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Proclaim
Series B in 2022
Fresh is a company that specializes in personalized oral care services and the development of solutions aimed at preventing oral diseases. Founded in 2017 by Mike Hanuschik and headquartered in Mountain View, California, Fresh focuses on addressing oral health issues that can lead to serious systemic diseases, such as diabetes, pancreatic cancer, Alzheimer’s, pneumonia, and heart disease. The company’s platform offers innovative remedies to improve oral health and ensure fresh breath for patients, contributing to overall well-being.
Vitara Biomedical
Series B in 2022
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.
PolyAI
Series B in 2022
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Founded in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on creating enterprise voice assistants capable of engaging in natural conversations with customers. These assistants utilize advanced machine learning and natural language processing to understand and respond to customer inquiries, regardless of phrasing or dialect. The platform supports features such as multilingual capabilities, data acquisition, and dynamic flow design, facilitating the creation of human-like interactions and improving customer service experiences across various industries.
Prellis Biologics
Series C in 2022
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.
Truework
Series C in 2022
Truework is a platform that facilitates the verification of income and employment for banks, lenders, and other entities. By integrating with human resources and payroll systems, as well as sectors like lending and housing, the platform automates the processing of employment and income requests. This capability allows financial institutions and background check providers to efficiently approve or deny requests for verification. Truework emphasizes consumer control over personal data, positioning itself as a key player in the financial services and fintech sectors. Its API-enabled solution streamlines the verification process, enhancing efficiency for users in need of reliable employment and income information.
TeraWatt Technology
Series B in 2022
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, specializes in the design and development of lithium-ion rechargeable batteries for various electrified applications. The company focuses on producing batteries that combine energy and power density with safety, catering to the needs of industrial clients. Through advanced engineering practices and efficient production processes, TeraWatt Technology aims to provide long-lasting, safe, and reliable power alternatives, supporting a wide range of electrification initiatives. Additionally, TeraWatt has a subsidiary located in Tokyo, Japan, further expanding its reach in the global market.
Oobli
Series B in 2022
Oobli specializes in the development of healthy, protein-based sweeteners sourced from exotic plants. These unique compounds offer a flavorful experience without the calories typically associated with sugar, making them a suitable alternative for health-conscious consumers. The protein sweeteners are produced through fermentation, ensuring they have no glycemic impact and do not disrupt the gut microbiome. Oobli has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for several of its proteins, reinforcing their commitment to safety and quality. By providing a delicious and low-calorie option, Oobli aims to transform the way individuals approach sweeteners, allowing for healthier choices in everyday consumption.
Mirvie
Series B in 2022
Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.
Loop
Series B in 2022
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.
Ellevest
Series B in 2022
Ellevest, Inc. is an investment management firm founded in 2014 and based in New York City, focusing primarily on providing financial services to women. The firm manages customized client portfolios across various asset classes globally, employing fundamental analysis and a top-down approach in its investment strategy. Ellevest has developed a digital investment platform that offers a personalized experience, utilizing proprietary algorithms tailored to women's financial needs, including salary peaks and goal-specific portfolios. This platform aims to empower female investors by helping them take control of their investments and achieve their financial goals through a user-friendly interface and thoughtful portfolio construction.
WorldCoin
Series B in 2022
World is a company that connects users through a privacy-focused network designed for secure digital asset management. It offers a digital currency platform that emphasizes both privacy and transparency using a permissionless blockchain. The World App enables users to securely store their World ID, manage digital assets, and access various Mini Apps, promoting global connectivity and trust. Additionally, World provides an iris-scanning device that enhances digital identity security by storing biometric information, which helps discourage spammers from creating multiple accounts. This combination of secure identity management and digital currency aims to facilitate a reliable and user-friendly digital environment.
Hermeus
Series B in 2022
Hermeus Corporation, founded in 2018 and headquartered in Atlanta, Georgia, specializes in the development of hypersonic aircraft designed to enhance global transportation. The company's Mach 5 jets are capable of flying at speeds exceeding five times the speed of sound, significantly reducing travel times for long-haul flights. For instance, a journey from New York to London can be completed in just 90 minutes, compared to the typical seven-hour duration. Hermeus aims to improve safety and efficiency in business class air travel while allowing for seamless integration with existing aviation infrastructure. This innovative approach not only accelerates travel but also fosters enhanced connectivity among global cities.
Homebound
Series C in 2022
Homebound Inc. is a technology-driven custom home builder based in Santa Rosa, California, founded in 2017. The company specializes in constructing residential homes and offers a comprehensive range of support services, including architecture, design, financing, and insurance consultancy. Originating in response to the 2017 Northern California wildfires, Homebound aims to simplify the homebuilding process by providing a transparent and streamlined experience for homeowners. It manages the entire building journey, assisting clients from insurance negotiation and architectural design to permitting and construction. By leveraging user-friendly technology and a network of qualified building professionals, Homebound addresses the complexities and uncertainties homeowners face, particularly in the aftermath of natural disasters, enabling them to rebuild their homes more efficiently.
Polly
Series B in 2022
PollyEx, Inc. operates a loan trading platform focused on the mortgage capital markets, facilitating transactions between buyers and sellers of mortgage loans. Founded in 2017 and based in San Francisco, California, PollyEx enhances loan sale execution through its cloud-based platform, which integrates with buyers and sellers via API, thereby increasing liquidity and automating various functions within capital markets. The platform aims to provide pricing transparency and improve operational efficiency for lenders, enabling them to make informed decisions throughout the lifecycle of a loan.
Prellis Biologics
Series B in 2021
Prellis Biologics, Inc. specializes in creating human tissues for drug development and the eventual production of human organs for transplantation. Founded in 2016 and based in San Francisco, California, the company employs advanced bioprinting technology to develop vascularized human tissues and organs, aiming to overcome the challenges associated with microvasculature. Its innovative products include TissueWorkshop, Organoids, Vascular Bundles, Tissue Chips, and Holograph X. Prellis Biologics also focuses on accurately replicating the human immune response through lymph node organoids, which can be utilized for various applications such as antibody discovery and immunogenicity assessment. By addressing critical issues in early-stage drug development and translational pharmacology, Prellis Biologics seeks to improve patient outcomes in healthcare.
Robin Healthcare
Series B in 2021
Robin Healthcare, Inc. is a healthcare technology company that focuses on enhancing the medical industry through innovative software solutions. Founded in 2017 and headquartered in Berkeley, California, with an additional office in Austin, Texas, the company provides a range of services including clinical documentation solutions, medical scribe services, order and medication entry, chart review, billing and coding, and referral management. By integrating technology with trained medical scribes, Robin Healthcare aims to streamline administrative tasks and improve the doctor-patient experience, allowing healthcare professionals to dedicate more time to patient care while maintaining control over their practices.
CloudTrucks
Series B in 2021
CloudTrucks is a company that provides a virtual trucking carrier application aimed at lowering operating costs for truck drivers. Founded in 2019 and based in San Francisco, California, the platform facilitates the management and booking of loads from brokers and shippers. It offers features such as instant payments upon delivery and access to affordable insurance options. These tools empower truck owners and operators to optimize their schedules and create strategies that enhance their revenue potential.
Lessen
Series B in 2021
Lessen is a technology-driven company that provides comprehensive outsourced property services for real estate rental assets, primarily focusing on single-family and multifamily renovations, turnovers, and maintenance. The company's platform facilitates seamless connections between real estate owners and service providers, offering on-demand resources and predictable service costs. Through its proprietary technology suite, Lessen enhances project management by incorporating automation and real-time analytics, thereby modernizing traditional processes in the industry. The company employs professional field project managers who ensure quality service and leverage a network of vetted service professionals across more than 40 markets nationwide. Lessen's approach enables efficient job verification, timely maintenance, and consistent service delivery for property owners and service providers alike.
Up&Up
Series B in 2021
Up&Up is a New York-based platform that facilitates fractional homeownership, providing a unique approach to renting and owning a home. Founded in 2017, the company allows renters to invest in their rental properties, enabling them to benefit from home price appreciation and accumulate ownership stakes through their rent payments. This model aims to make homeownership more accessible and flexible, allowing residents to build equity while maintaining the convenience of renting. By offering a rewarding alternative to traditional rental agreements, Up&Up helps individuals work towards their homeownership goals while also minimizing maintenance and property management costs.
OpenStore
Series B in 2021
OpenStore is a company that provides instant liquidity services to eCommerce entrepreneurs, facilitating a seamless connection between merchants and customers. By leveraging data, information, and capital, OpenStore aims to enhance the online shopping experience, allowing for spontaneous discovery. The company's services enable merchants to concentrate on their core business operations while benefiting from improved access to financial resources. Ultimately, OpenStore seeks to create a unified platform that transforms the way merchants engage with customers in the digital marketplace.
Heyday
Series C in 2021
Heyday is a skincare services company that provides customized facial treatments through its chain of stores, which are primarily located in New York. Founded in 2015 by Adam Ross, Jeni Sykes, and Michael Pollak, Heyday focuses on offering a personalized skincare experience, including deep cleansing, skin analysis, exfoliation, extractions, masks, hydration, and SPF protection. In addition to its core services, the company also enables customers to purchase a range of skincare products at competitive prices. With a commitment to blending expertise and data, Heyday empowers individuals to take better care of their skin. The company operates an online platform that accelerates consumer product brands on digital marketplaces, further enhancing its reach and impact in the skincare industry.
Viome Life Sciences
Series C in 2021
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Because Market
Series B in 2021
Because Market is a direct-to-consumer personal care company established in 2017, specializing in products tailored for older adults. The company aims to simplify access to essential health and wellness items, including incontinence underwear, pads, skincare, supplements, and walkers. By providing discreet delivery and flexible subscription options, Because Market facilitates the purchasing process for families seeking to support their senior members. With aspirations to become the most trusted brand in this sector, the company has secured over $40 million in funding from prominent venture capital firms, reflecting its commitment to enhancing the lives of older adults and promoting their independence.
Lightship
Series C in 2021
Lightship is a company founded in 2018 that focuses on enhancing access, choice, and equity in clinical trials through decentralized and hybrid clinical services. By leveraging innovations in digital health and technology, Lightship aims to transform the clinical research landscape by improving patient experiences, retention, and trial diversity. The company moves beyond traditional research centers to make clinical studies more accessible, allowing medical research organizations to overcome the barriers and inefficiencies associated with conventional clinical trial models. Its mission centers on placing patients at the forefront, ensuring that clinical research is designed to meet the needs of diverse populations globally.
All Day Kitchens
Series C in 2021
All Day Kitchens develops delivery-optimized kitchens that support restaurants in adapting to the digital, delivery, and pick-up landscape. By leveraging data, the company identifies and secures prime locations for cloud kitchens, allowing restaurants to expand their reach without significant upfront costs. Their platform facilitates the establishment of technical networks that enhance food delivery operations, enabling restaurants to thrive in a competitive market.
OpenTrons
Series C in 2021
Opentrons is a company that specializes in the development of pipetting robot technology aimed at automating laboratory experiments. By utilizing open-source principles, Opentrons provides a range of lab automation solutions, including robots, workstations, hardware modules, consumables, reagents, and labware. Their technology leverages the Python programming language to streamline experimental processes, making them faster and reducing the likelihood of human error. This focus on automation allows scientific researchers to enhance efficiency and accuracy in their work, ultimately advancing their research capabilities.
Statespace
Series C in 2021
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.
Eight Sleep
Series C in 2021
Eight Sleep, Inc. is a sleep technology company based in New York, focused on improving sleep quality through innovative smart mattresses and related accessories. Founded in 2014, the company manufactures products that include mattresses, sleep trackers, pillows, organic sheets, foundations, and various sleep-related items such as gravity blankets and blue wave glasses. Eight Sleep's mattresses are designed to regulate temperature, adjusting to the body's natural rhythms for optimal comfort, while also tracking health metrics to enhance sleep quality. The company emphasizes the importance of sleep for overall health and daily performance and sells its products primarily through online channels. Formerly known as Morphy, Inc., Eight Sleep has gained recognition as a leader in sleep technology and was honored as one of the Most Innovative Companies in Consumer Electronics by Fast Company in 2018.
Bungalow
Series C in 2021
Bungalow is a residential real estate platform that facilitates flexible and communal living arrangements for renters, particularly targeting early career professionals. Founded in 2016 by Andrew Collins and Justin McCarty, the company is headquartered in San Francisco, California. Bungalow signs long-term leases with homeowners to offer multi-bedroom homes in desirable urban neighborhoods across the United States. Each property features private bedrooms with handpicked housemates, and comes fully furnished with essential amenities such as Wi-Fi, utilities, and housekeeping. Additionally, Bungalow organizes monthly community events to foster social interaction among residents. By addressing the needs of modern renters, Bungalow provides a convenient solution for those seeking quality living environments while cultivating a sense of community.
Kiddom
Series C in 2021
Kiddom, established in 2013 and headquartered in San Francisco, specializes in developing a comprehensive, visual collaborative platform for K-12 classrooms. This platform integrates curriculum management, instruction, assessment, and communication tools, streamlining educational processes and saving resources. It supports various learning scenarios, including in-class, blended, hybrid, and distance learning, and facilitates real-time interaction between teachers and students.
Homebase
Series C in 2021
Homebase is a developer of employee management software focused on simplifying the administrative tasks associated with hourly work. The platform offers tools for scheduling, time tracking, and communication, all designed to minimize the burden on employers and employees alike. Its cloud-based system allows users to manage timesheets and track hours from any location, facilitating efficient payroll preparation. While the basic features are available for free, Homebase also provides tiered pricing options for businesses seeking additional functionalities. By streamlining these processes, Homebase aims to help organizations save time and improve coordination among their teams.
Deep Genomics
Series C in 2021
Deep Genomics Inc. is an artificial intelligence therapeutics company that focuses on developing individualized genetic medicines. Founded in 2014 and based in Toronto, Canada, the company utilizes advanced AI systems to enhance various stages of drug discovery and development, including target identification, lead optimization, toxicity evaluation, and trial design. Deep Genomics specializes in creating oligonucleotide therapies that address the genetic causes of diseases at the RNA and DNA levels. Its innovative AI-powered platform analyzes RNA biology to uncover new therapeutic targets and mechanisms that traditional methods cannot access, enabling the development of treatments for rare metabolic, ophthalmologic, and neurodegenerative disorders. The company recruits top talent in genomics, drug development, and AI to drive its mission of revolutionizing drug discovery.
HealthifyMe
Series C in 2021
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.
AttackIQ
Series C in 2021
AttackIQ, Inc. is a cybersecurity company that specializes in providing a Breach & Attack Simulation (BAS) platform designed to help organizations assess the effectiveness of their security controls. Founded in 2013 and headquartered in San Diego, California, with additional offices in Sydney and Melbourne, Australia, the company's platform allows security teams to simulate real-world attack scenarios based on the MITRE ATT&CK framework. This enables organizations to validate their security measures, uncover vulnerabilities, and prioritize remediation efforts. The platform integrates into existing networks, offering visibility into security programs and facilitating continuous testing against adversary techniques. By automating security assessments, AttackIQ empowers organizations to identify weaknesses in their defenses and ensure that their security architecture is robust and responsive to emerging threats.
Mighty Buildings
Series B in 2021
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacture of 3D printed custom homes. Utilizing advanced construction technology, the company employs 3D printing, robotics, and automation to create modular homes that aim to disrupt the residential housing market. Mighty Buildings has developed a proprietary building material known as Light Stone Material (LSM), which mimics synthetic stone and provides advantages such as faster construction, zero waste, and improved thermal regulation compared to traditional materials like concrete, wood, or steel. The company's innovative approach focuses on producing prefabricated, environmentally friendly, and climate-resilient homes, thereby facilitating smart urban development and making housing more affordable.
Sword Health
Series C in 2021
Sword Health is a digital health company specializing in physical rehabilitation. It employs artificial intelligence to deliver personalized care to patients worldwide, anytime, anywhere. The platform offers interactive exercise routines supervised by remote physiotherapists, aiming to reduce costs and improve accessibility to physical therapy. Clinicians can utilize the data collected to enhance decision-making processes.
Fortera
Series B in 2021
Fortera is focused on developing innovative cement products that significantly reduce carbon dioxide emissions associated with concrete production. The company has created a process that captures industrial carbon emissions and mineralizes them to produce a less carbon-intensive form of concrete. This method not only aims to lower the environmental impact of construction but also enhances the performance characteristics of their products compared to traditional concrete. By providing a more sustainable alternative, Fortera contributes to the global effort to mitigate greenhouse gas emissions, addressing a critical challenge in the construction industry.
Imply
Series C in 2021
Imply, founded by the original creators of Apache Druid, offers a comprehensive real-time analytics platform that leverages the capabilities of Apache Druid, an open-source database designed for next-generation analytics. The platform enables organizations to handle event-driven and streaming data with high scalability and rapid data visualization, allowing decision-makers to access petabyte-scale datasets efficiently. Imply focuses on a category it terms "analytics-in-motion," which emphasizes interactive and cost-effective analytics solutions as opposed to traditional static approaches. By supporting real-time ingestion and analysis, Imply empowers leading companies globally to enhance their business intelligence and operational analytics. The company operates in North America, Europe, and Asia Pacific, receiving backing from notable investors in the technology sector.
Synchron
Series B in 2021
Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.
Hello Heart
Series C in 2021
Hello Heart Inc. is a health technology company that offers a comprehensive application designed to help individuals manage their blood pressure effectively. Founded in 2013 and based in Redwood City, California, the company provides users with a wireless blood pressure monitor paired with a smartphone application that delivers real-time, personalized health tips. The application is particularly aimed at individuals with high blood pressure, empowering them to understand and improve their heart health. By facilitating self-management and promoting behavior change, Hello Heart seeks to prevent serious health risks associated with hypertension, which is a major cost factor for employers. The program is clinically based, ensuring that users receive reliable guidance in an engaging manner.
Clear Labs
Series C in 2021
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.
Overture Life
Series B in 2021
Overture Life, Inc. is a biotechnology company established in 2017 and headquartered in New York, New York. The company specializes in developing robotic technology and medical devices aimed at automating the in vitro fertilization (IVF) process. Overture Life's innovations include novel embryo testing methodologies and automated cryopreservation services, which help fertility clinics identify viable embryos prior to implantation. By streamlining the IVF process, Overture Life aims to make artificial insemination more accessible, reduce costs, optimize resource use, and improve success rates for practitioners and patients alike.
Heyday
Series B in 2021
Heyday is a skincare services company that provides customized facial treatments through its chain of stores, which are primarily located in New York. Founded in 2015 by Adam Ross, Jeni Sykes, and Michael Pollak, Heyday focuses on offering a personalized skincare experience, including deep cleansing, skin analysis, exfoliation, extractions, masks, hydration, and SPF protection. In addition to its core services, the company also enables customers to purchase a range of skincare products at competitive prices. With a commitment to blending expertise and data, Heyday empowers individuals to take better care of their skin. The company operates an online platform that accelerates consumer product brands on digital marketplaces, further enhancing its reach and impact in the skincare industry.
Pendulum Therapeutics
Series C in 2021
Pendulum Therapeutics Inc. is a microbiome-focused company based in San Francisco that specializes in developing medical probiotics and prebiotics aimed at managing chronic illnesses, particularly type 2 diabetes. The company's flagship product, Pendulum Glucose Control, was introduced in 2020 and has demonstrated effectiveness in lowering blood sugar spikes and reducing A1C levels, as evidenced by published clinical trials. Pendulum utilizes evidence-based microbiome science and DNA sequencing to create targeted interventions, allowing clinicians to identify specific microbiome markers for disease treatment. Founded in 2013, Pendulum holds 13 patents and has 42 pending, with significant backing from prominent investors. The company sells its products online, focusing on improving healthcare through innovative microbiome therapies.
Rightway
Series C in 2021
Rightway is a technology and services company focused on simplifying healthcare for clients and their members. The company develops care navigation and pharmacy benefit management (PBM) solutions aimed at reducing healthcare spending by guiding members toward optimal care and therapies. Rightway's mission centers on using guidance and advocacy to lower costs and improve healthcare outcomes by aligning incentive models and integrating clinicians into the care journey. Its modern care navigation technology offers clinical guidance at a lower cost compared to traditional solutions. Additionally, Rightway's innovative PBM model ensures that every prescription is directed towards the lowest net cost, thereby minimizing expenses for members. The company’s transparent approach to pharmacy benefits is unique in that it incorporates care navigation, enhancing the overall member experience and engagement while addressing total cost-of-care.
Scipher Medicine
Series C in 2021
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.